Goldman Sachs Group Inc Vertex Pharmaceuticals Inc Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $46,000 - $50,578	-100 Reduced 1.04%	9,500 $4.42 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $9.55 Million - $11.8 Million	-24,300 Reduced 71.68%	9,600 $4.5 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $1.71 Million - $1.87 Million	4,200 Added 14.14%	33,900 $14.2 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $1.44 Million - $1.72 Million	-4,200 Reduced 12.39%	29,700 $12.1 Million
Q3 2023 May 14, 2024	BUY	$338.18 - $362.46 $1.42 Million - $1.52 Million	4,200 Added 14.14%	33,900 $11.8 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $6.53 Million - $7 Million	-19,300 Reduced 36.28%	33,900 $11.8 Million
Q2 2023 May 14, 2024	SELL	$314.42 - $351.91 $17.5 Million - $19.5 Million	-55,500 Reduced 51.06%	53,200 $18.7 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $17.5 Million - $19.5 Million	-55,500 Reduced 51.06%	53,200 $18.7 Million
Q1 2023 May 14, 2024	BUY	$283.23 - $323.1 $4.33 Million - $4.94 Million	15,300 Added 16.38%	108,700 $34.2 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $4.33 Million - $4.94 Million	15,300 Added 16.38%	108,700 $34.2 Million
Q4 2022 May 14, 2024	BUY	$285.76 - $321.48 $15.8 Million - $17.7 Million	55,200 Added 144.5%	93,400 $27 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $15.8 Million - $17.7 Million	55,200 Added 144.5%	93,400 $27 Million
Q3 2022 May 14, 2024	BUY	$273.83 - $305.53 $2.33 Million - $2.6 Million	8,500 Added 28.62%	38,200 $11.1 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $10.5 Million - $11.7 Million	38,200 New	38,200 $11.1 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $2.39 Million - $2.82 Million	-10,800 Reduced 23.53%	35,100 $9.16 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $5.47 Million - $6.9 Million	30,900 Added 206.0%	45,900 $10.1 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $2.72 Million - $3.04 Million	15,000 New	15,000 $2.72 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.8 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.33 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.58 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.76 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.63 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account